Understanding Terpenes in Cannabis: The Role of Myrcene

Myrcene is one of the most common aromatic compounds (terpenes) found in medicinal cannabis. It is often associated with "relaxing" or "night-time" products, but the science is more nuanced than social media would suggest. This article gives a clinically balanced, patient-friendly overview of what we know (and don't know) about myrcene. It is general information only and does not replace individual medical advice.

Key takeaways

• Myrcene is one of the most common terpenes in cannabis and also occurs in plants such as hops, lemongrass and mango.[1]
• Preclinical studies suggest myrcene has anti-inflammatory, analgesic and sedative-like properties, and may contribute to the "heavier" or more relaxing feel of some cannabis products.[1,2,5–7,10]
• The idea that myrcene alone explains couch-lock or profound sedation is an oversimplification. The overall effect you experience is driven by the full terpene and cannabinoid profile, the dose, the route of administration, and your own biology.[3,4,10]
• Myrcene may enhance or modify the effects of THC and CBD through the entourage effect, but human clinical data specifically isolating myrcene's contribution are still limited.[3,4,8]
• While myrcene is generally recognised as safe in food and cosmetics at normal exposures, the US FDA removed synthetic myrcene from its approved food-additive list in 2018 due to high-dose animal data. European authorities have set exposure limits but consider food-level exposures acceptable.[8,9]
• If you are interested in terpene profiles, discuss options with your prescriber. Consider keeping a journal to track which product profiles suit you best.

What is myrcene?

Myrcene (also written as β-myrcene) is a monoterpene, which means it is a relatively small, volatile aromatic molecule. It is one of the most abundant terpenes found in the essential-oil fraction of many cannabis cultivars and is also present in hops, lemongrass, mangoes, thyme, bay leaves, and other plants.[1]

Its aroma is typically described as earthy, musky, or herbal, sometimes with a slightly fruity note. When a cannabis product is described as "dank" or "skunky", myrcene often contributes to that profile.[1]

What does the research say about myrcene's effects?

Most published data come from animal models and in vitro (cell-based) studies. In these experiments, myrcene has been reported to:

**Reduce pain:** Animal studies using chemical and thermal pain models have shown analgesic effects, with one proposed mechanism involving the opioid system.[2,5–7]

**Reduce inflammation:** In a rat model of monoarthritis, cannabis terpene extracts rich in myrcene showed significant anti-inflammatory and analgesic effects, even without THC.[2]

**Induce sedation and muscle relaxation:** One often-cited mouse study reported sedative and muscle-relaxant effects at high doses of myrcene.[5] A broader review also suggests sedative-hypnotic activity of β-myrcene within essential-oil preparations.[7]

These findings support the idea that myrcene might contribute to more relaxing effects when present in higher amounts. However, several important caveats apply:

• These are animal studies, often using doses much higher (per kg body weight) than typical human exposure from cannabis or food.
• Human data linking specific myrcene levels to sedation are limited and mostly observational.
• The overall effect you feel is driven by multiple factors: THC and CBD dose, other terpenes, route of administration, your prior exposure, mental state, sleep, other medications and underlying health.[3,4,10]

In other words: myrcene may be one contributor to a "heavier" or more relaxing profile, but it is not the only variable. The idea that eating a mango (which contains myrcene) will dramatically increase your "high" remains a myth rather than an evidence-based recommendation.[1,3]

Myrcene and the entourage effect

The entourage effect is the hypothesis that the therapeutic and subjective effects of cannabis are shaped by the interaction of cannabinoids (THC, CBD, CBG, etc.) with terpenes and other plant compounds, rather than by any single molecule acting alone.[3,4]

Myrcene is one of the terpenes most frequently discussed in this context. There is theoretical and preclinical support for the idea that myrcene:

• May help THC cross the blood-brain barrier more efficiently — though this specific claim is still debated and not conclusively proven in humans.[3,10]
• May synergise with CBD's anti-inflammatory pathway through shared mechanisms (e.g., both have been linked to prostaglandin E-2 inhibition and TRPV1 modulation).[2,4]
• May contribute to the overall "indica-like" versus "sativa-like" feel of a product, though these categories are an unreliable guide to chemical content.[10]

A well-designed 2022 preclinical study showed that a terpene extract from cannabis (containing myrcene, pinene, limonene, linalool, and others) reduced inflammatory joint pain in rats even without THC present, suggesting terpenes have independent biological activity.[2]

This does not mean that "more myrcene = better", or that myrcene alone is responsible for relaxation. But it does support the concept that terpene composition matters when evaluating a product's overall therapeutic profile.

Regulatory and safety perspective

Myrcene has a long history of use in food flavouring and cosmetics, and is generally considered safe at typical exposure levels.

However, in 2018, the US FDA removed synthetic beta-myrcene from its list of approved food additives under the Delaney Clause. This decision was based on animal studies showing kidney tumours at very high chronic doses — not at levels found in natural food sources. Because the Delaney Clause is an absolute law (which prohibits listing any additive with evidence of carcinogenicity in animals), the FDA removed synthetic myrcene from the permitted food-additive list, despite actual human risk at normal exposures being considered low.[9]

European assessments (for example, EFSA) have considered myrcene as part of broader groups of flavouring substances and have used standard toxicology approaches (NOAELs, margins of safety) to set acceptable exposure limits for food use.[8]

These decisions relate to added synthetic myrcene in food, not to naturally occurring myrcene in plants such as cannabis or hops. Nonetheless, they remind us that "natural" does not always mean risk-free, and that dose and route of administration matter.

Practical considerations for patients

When myrcene is present as part of a cannabis product:

• Side effects are usually dominated by THC (for example, dizziness, dry mouth, anxiety, impaired driving) rather than by myrcene itself.
• Myrcene-rich products might feel slightly more sedating or body-heavy, which may be a benefit for sleep or a drawback for daytime alertness.
• Keeping a journal of product names, terpene profiles, dosage, and your response can help you and your prescriber identify what works best.
• If you find one product too sedating and another too stimulating, the terpene profile (not just the THC content) may be part of the explanation.

References

1. Surendran S, Qassadi F, Lilley D, et al. Myrcene—What Are the Potential Health Benefits of This Flavouring Agent? Frontiers in Nutrition. 2021;8:699666. 2. McDougall JJ, et al. Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis. Pain. 2022. 3. Russo EB. Taming THC: Potential Cannabis Synergy and Phytocannabinoid–Terpenoid Entourage Effects. British Journal of Pharmacology. 2011;163(7):1344–1364. 4. Andre R, et al. The Entourage Effect in Cannabis Medicinal Products: From Molecular Mechanisms to Clinical Evidence. Pharmaceuticals. 2024. 5. do Vale TG, Furtado EC, Santos JG Jr, Viana GS. Central Effects of Citral, Myrcene and Limonene, Constituents of Essential Oils. Pharmacology Biochemistry and Behavior. 2002;71(1–2):251–259. 6. Rao VS, Menezes AM, Viana GS. Effect of Myrcene on Nociception in Mice. J Pharm Pharmacol. 1990;42(12):877–878. 7. Guimaraes AG, Quintans JS, Quintans-Junior LJ. Monoterpenes with Analgesic Activity: A Systematic Review. Phytother Res. 2013;27(1):1–15. 8. EFSA Panel on Food Additives and Nutrient Sources. Scientific Opinion on Flavouring Group Evaluation. EFSA J. (multiple years). 9. US FDA. Removal of Certain Generally Recognized as Safe (GRAS) Uses of Food Flavoring Substances. Federal Register. 2018. 10. Ferber SG, et al. The "Entourage Effect": Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Current Neuropharmacology. 2020;18(2):87–96.